Purified Human MDR 1 Modulates Membrane Potential in Reconstituted Proteoliposomes
- 8 March 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 42 (12) , 3544-3555
- https://doi.org/10.1021/bi026706i
Abstract
Human multidrug resistance (hu MDR 1) cDNA was fused to a P. shermanii transcarboxylase biotin acceptor domain (TCBD), and the fusion protein was heterologously overexpressed at high yield in K+-uptake deficient Saccharomyces cerevisiae yeast strain 9.3, purified by avidin−biotin chromatography, and reconstituted into proteoliposomes (PLs) formed with Escherichia coli lipid. As measured by pH- dependent ATPase activity, purified, reconstituted, biotinylated MDR−TCBD protein is fully functional. Dodecyl maltoside proved to be the most effective detergent for the membrane solubilization of MDR−TCBD, and various salts were found to significantly affect reconstitution into PLs. After extensive analysis, we find that purified reconstituted MDR−TCBD protein does not catalyze measurable H+ pumping in the presence of ATP. In the presence of physiologic [ATP], K+/Na+ diffusion potentials monitored by either anionic oxonol or cationic carbocyanine are easily established upon addition of valinomycin to either control or MDR−TCBD PLs. However, in the absence of ATP, although control PLs still maintain easily measurable K+/Na+ diffusion potentials upon addition of valinomycin, MDR−TCBD PLs do not. Dissipation of potential by MDR−TCBD is clearly [ATP] dependent and also appears to be Cl- dependent, since replacing Cl- with equimolar glutamate restores the ability of MDR−TCBD PLs to form a membrane potential in the absence of physiologic [ATP]. The data are difficult to reconcile with models that might propose ATP-catalyzed “pumping” of the fluorescent probes we use and are more consistent with electrically passive anion transport via MDR−TCBD protein, but only at low [ATP]. These observations may help to resolve the confusing array of data related to putative ion transport by hu MDR 1 protein.Keywords
This publication has 17 references indexed in Scilit:
- MDR1 P-glycoprotein Reduces Influx of Substrates without Affecting Membrane PotentialJournal of Biological Chemistry, 2001
- Use of Chemical Chaperones in the Yeast Saccharomyces cerevisiae to Enhance Heterologous Membrane Protein Expression: High-Yield Expression and Purification of Human P-GlycoproteinArchives of Biochemistry and Biophysics, 2000
- Intracellular pH and Multidrug Resistance Regulate Complement-mediated Cytotoxicity of Nucleated Human CellsPublished by Elsevier ,1999
- Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?The Journal of general physiology, 1996
- The multidrug resistance phenotype confers immunological resistance.The Journal of Experimental Medicine, 1996
- Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cellsBiochemical Journal, 1995
- The human MDR3 P‐glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic miceFEBS Letters, 1994
- [39] Plasma membrane ATPase from the yeast Saccharomyces cerevisiaePublished by Elsevier ,1988
- A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: Application to lens ATPasesAnalytical Biochemistry, 1988
- Kinetic analysis of carrier-mediated ion transport by the charge-pulse techniqueThe Journal of Membrane Biology, 1976